Anti-MICB antibody [EPR26362-65]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal MICB antibody. Suitable for IP, Flow Cyt, WB, ICC/IF and reacts with Human, Recombinant full length protein - Human samples.
View Alternative Names
PERB11.2, MICB, MHC class I polypeptide-related sequence B, MIC-B
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-MICB antibody [EPR26362-65] (AB300485)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized K-562 (human chronic myelogenous leukemia lymphoblast) cells labelling MICB with ab300485 at 1/50 (9.62ug/mL) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2 ug/ml dilution (Green). Confocal image showing membranous staining in K-562 cell lineNegative control : Daudi (PMID : 19404979 ) is observed. ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2 ug/ml dilution.
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-MICB antibody [EPR26362-65] (AB300485)
Flow cytometric analysis of 293T (human embryonic kidney epithelial cell, Left) / Daudi (human Burkitt's lymphoma lymphoblast, Middle) / K562 (human chronic myelogenous leukemia lymphoblast, Right) cells labelling MICB with ab300485 at 1/500 dilution (0.1ug) (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/2000 dilution was used as the secondary antibody. Gated on viable cells.Negative control : 293T, Daudi (PMID : 28154561).
- IP
Supplier Data
Immunoprecipitation - Anti-MICB antibody [EPR26362-65] (AB300485)
MICB was immunoprecipitated from 0.35 mg K562 (human chronic myelogenous leukemia lymphoblast), whole cell lysate 10 ug with ab300485 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab300485 at 1/1000 dilution. VeriBlot for IP secondary antibody (HRP)(ab131366) was used at 1/5000 dilution. Lane 1 : K562 (human chronic myelogenous leukemia lymphoblast), whole cell lysate 10 ug Lane 2 : ab300485 IP in K562 whole cell lysate Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab300485 in K562 whole cell lysate. Blocking and dilution buffer and concentration : 5% NFDM/TBST. Exposure time : 180 seconds
Lane 1:
Immunoprecipitation - Anti-MICB antibody [EPR26362-65] (ab300485) at 1/30 dilution
Lane 2:
Immunoprecipitation - Anti-MICB antibody [EPR26362-65] (ab300485) at 1/1000 dilution
All lanes:
K562 whole cell lysate at 10 µg
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-MICB antibody [EPR26362-65] (AB300485)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
This antibody does not cross-react with human MICA.
All lanes:
Western blot - Anti-MICB antibody [EPR26362-65] (ab300485) at 1/1000 dilution
Lane 1:
Purified his-tagged human MICB recombinant protein at 10 ng
Lane 2:
Purified his-tagged human MICA recombinant protein at 10 EU/ng
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 43 kDa
Observed band size: 37-50 kDa
false
Exposure time: 7.75s
- WB
Supplier Data
Western blot - Anti-MICB antibody [EPR26362-65] (AB300485)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
MICB is a glycoprotein of approximately 61 kDa and detected as two 37-42 kDa bands after treated with Protein Deglycosylation MIX II.
The bands beneath the target band (37 kDa) are reported as deglycosylated cleaved soluble MICB.
Molecular weight observed is consistent with described in the literature (PMID : 19147769).
This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.
All lanes:
Western blot - Anti-MICB antibody [EPR26362-65] (ab300485) at 1/1000 dilution
Lane 1:
Untreated K562 (human chronic myelogenous leukemia lymphoblast), whole cell lysate at 15 µg
Lane 2:
K562 whole cell lysate treated with Protein Deglycosylation Mix II at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 43 kDa
Observed band size: 37-61 kDa
true
Exposure time: 103s
- WB
Supplier Data
Western blot - Anti-MICB antibody [EPR26362-65] (AB300485)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
The expression profile/molecular weight observed is consistent with what has been described in the literature (PMID : 10359807).
Negative control : Daudi, 293T (PMID : 28154561).
This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.
All lanes:
Western blot - Anti-MICB antibody [EPR26362-65] (ab300485) at 1/1000 dilution
Lane 1:
K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate at 40 µg
Lane 2:
U266B1 (human multiple myeloma B lymphocyte) whole cell lysate at 40 µg
Lane 3:
Daudi (human Burkitt's lymphoma lymphoblast) whole cell lysate at 40 µg
Lane 4:
293T (human embryonic kidney epithelial cell) whole cell lysate at 40 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>)
Predicted band size: 43 kDa
Observed band size: 37-61 kDa
true
Exposure time: 48s
Related conjugates and formulations (3)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Rabbit monoclonal [EPR26362-65] to MICB
-
578 PE
PE Anti-MICB antibody [EPR26362-65]
-
Anti-MICB antibody [EPR26362-65] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MICB contributes to immune system functioning by presenting stress-induced antigens to immune cells. It does not belong to a complex but engages in interactions critical for activating cytotoxic responses. By binding to the NKG2D receptor it helps activate NK cells and certain T cell subsets which results in the elimination of damaged or transformed cells. This immune activation is important for the surveillance against cancer and infected cells maintaining tissue homeostasis.
Pathways
MICB plays a role in the stress-induced NKG2D signaling pathway and is involved in the immune response pathway. It cooperates with proteins such as NKG2D and MICA another ligand of the NKG2D receptor to initiate immune cell-mediated cytotoxicity. These pathways activate NK cells and CD8+ T cells important for removing stressed or altered cells thereby influencing the body's defense mechanisms.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com